GPCRs With mTOR Signaling Expressed in Gut-Brain-Immune Axis-Cells Could Contribute to the Treatment of Neurodegenerative Diseases and Immune-Related Diseases

Akari Fukumoto, Naoko Suga, Moeka Nakashima, Satoru Matsuda

PDF(1057 KB)
For Authors|For Editors|For Reviewers
PDF(1057 KB)
Discovery Medicine ›› 2025, Vol. 37 ›› Issue (195) : 608-617. DOI: 10.24976/Discov.Med.202537195.53
Review

GPCRs With mTOR Signaling Expressed in Gut-Brain-Immune Axis-Cells Could Contribute to the Treatment of Neurodegenerative Diseases and Immune-Related Diseases

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

Highlight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 37(195): 608-617 https://doi.org/10.24976/Discov.Med.202537195.53

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1057 KB)

Accesses

Citation

Detail
Sections
Recommended
Follow Us on
Copyright © 2025.
By using this website, you agree to our Terms & Conditions and Privacy Policy.  
  • Disclaimer
    The statements, opinions and data contained in Discovery Medicine are solely those of the individual authors and contributors and not of the journal and the editor(s). Discovery Medicine stays neutral with regard to jurisdictional claims in published maps and insitutional affiliations.

    • /

    〈 〉